Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

What are the Molecular Mechanisms of Axonal Degeneration in Stroke?
Cerebrovascular Disease and Interventional Neurology
S22 - Cerebrovascular Disease and Interventional Neurology: Biomarkers, Mechanisms of Axonal Injury, Stroke, and Infection (2:08 PM-2:16 PM)
002

Functional preservation of axons after ischemic stroke is limited yet critical to post-stroke recovery. Genetic deletion of SARM1 gene has previously been shown to prevent axonal degeneration after traumatic nerve injuries. However, whether similar mechanism mediates axonal loss in ischemic injury is unclear. We sought to understand whether SARM1 activity directly regulates axonal as well as neuronal survival in ischemic stroke.

1. Determine if loss of SARM1 activity promotes axonal survival following ischemic injury.

2. Identify molecular targets of SARM1 in mediating axonal degeneration in stroke.


We utilized an in vivo model of subcortical white matter stroke to compare the degree of axonal and neuronal survival between wildtype (WT) and SARM1 null (SARM1-/-) mice after ischemic injury. Furthermore, using cell capture and RNA-seq analysis, we profiled the molecular signature of SARM1-/- neurons after stroke to elucidate the downstream targets of SARM1-dependent regulation of axonal survival following ischemic injury.

We found that genetic deletion of SARM1 robustly attenuated both axonal and neuronal degeneration for up to 28 days after focal ischemic injuries to the subcortical white matter. Thus, inhibiting SARM1 activity is sufficient to promote axonal and neuronal survival after ischemic stroke. Moreover, transcriptional profiling of stroke-injured wildtype and SARM1-/- neurons revealed a restricted subset of differentially expressed genes that drive neuronal differentiation, axonogenesis and synaptogenesis. Functional genomic analysis of candidate genes further uncovered novel cell signaling pathways that regulate axonal and neuronal survival after stroke injuries.

The results show that axonal degeneration from ischemic injuries occurs through a shared Wallerian mechanism, and SARM1 is a critical regulator of axonal and neuronal survival after ischemic stroke. The results help delineate a novel molecular pathway mediating axonal degeneration following injury, and indicate that inhibiting SARM1 activity is a potent and novel therapeutic strategy to enhance axonal and neuronal survival after ischemic stroke.
Authors/Disclosures
Jack T. Wang, MD, PhD (Stanford University Medical Center)
PRESENTER
Dr. Wang has received personal compensation in the range of $0-$499 for serving as a Consultant for Guidepoint. Dr. Wang has received personal compensation in the range of $0-$499 for serving as a Consultant for Alpha Insight. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medical Education Speakers Network. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Sutton Pierce. Dr. Wang has received research support from AHA. Dr. Wang has received research support from Alzheimer's Association. Dr. Wang has received research support from Neurocritical Care Society. Dr. Wang has received research support from AAN.